Font Size: a A A
Keyword [bowel disease]
Result: 161 - 180 | Page: 9 of 10
161. Gadolinium Chloride Improves The Course Of TNBS And Dss-induced Colitis Through Protecting Against Colonic Mucosal Inflammation
162. The Role Of PGRN In The Pathogenesis Of Experimental Colitis And Potential Mechanism
163. Study Of A Novel And Potential Susceptibility Gene To Crohn’s Disease In A Chinese Family By Exome Sequencing And Bioinformatics Methods
164. The Research Of Over-expression Of CXCR4on Mesenchymal Stem Cells Protect Against Ulcerative Colitis And Synergistic Effect Of Compound Sophorae Decoction
165. The Molecular Mechanism Study Of Jiawei Huangqin Decoction Regulating IL-6/STAT3Signaling Pathway To Inhibit Cancerization Of Inflammatory Bowel Disease (IBD) On The Basis Of "Preventing Disease From Exacerbating" Theory
166. The Role Of Th-1and Th-17Cytokines In The Pathogenesis Of Murine Autoimmune Cholangitis And Colitis
167. Pogostone Ameliorates TNBS-induced Inflammatory Bowel Disease:An Immunomodulation Study On T Cell
168. The Role Of Stress And Coping Behavior In Inflammatory Bowel Disease
169. The Epidemiological Characteristics, Environmental Factors And Relapse Factors In Inflammatory Bowel Disease In Yunnan Province
170. Aryl Hydrocarbon Receptor Activation Involved In Ameliorating Inflammatory Bowel Disease And The Regulation Of Intestinal Epithelial Derived IL-7
171. The Effect Of Heme Oxygenase-1 On Inflammatory Boweldisease By Regulating And Suppressing Th17 Cells
172. HMGB1 Regulates Th17 Response Involved In The Pathogenesis Of Experimental Colitis In Mice And Aloe Emodin Intervention Study
173. Alterations And Clinical Efficacy Accessment Of Syndecan-1 In Inflammatory Bowel Diseases
174. Triptolide Ameliorates Intestinal Inflammation In Inflammatory Bowel Disease (Crohn’s Disease) By Mechanisms Involving Suppression Of IL-6/STAT3 Signaling Pathway
175. Characteristics Of Predominant Intestinal Microbiota And The Relationships Between The Pathogenesis And The Enterobacteria Communities In Chinese Patients With Irritable Bowel Syndrome And Inflammatory Bowel Disease
176. Preliminary Study On The Therapeutic Mechanism For Inflammatory Bowel Disease And Solid Preparation Of Allyl Methyl Disulfide
177. Citrus Nobiletin Rebanlances Intestinal Dysmotility And Suppresses Trinitrobenzene Sulfonic Acid-induced Experimental Colitis
178. Distinct Dysbiosis Ocurred In Inflammatory Bowel Disease During Quiescent Stage
179. The Role Of INKT Cells, CCL25/CCR9 Interaction And Hyperhomocysteinemia In The Pathogenesis Of Inflammatory Bowel Disease
180. Proteomic Screening Of Disease Specific And Treatment Monitoring Serum Biomarkers Of Inflammatory Bowel Disease
  <<First  <Prev  Next>  Last>>  Jump to